Related Experiment Video
Updated: Aug 25, 2026

Using a Chemical Biopsy for Graft Quality Assessment
Published on: June 17, 2020
Biomarkers and surrogate endpoints in renal transplantation: present status and considerations for clinical trial
Peter A Lachenbruch1, Amy S Rosenberg, Ezio Bonvini
1Division of Biostatistics, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, FDA, Rockville, MD, USA.
Abstract:
Of major importance in clinical trials is the ability to predict individual patient outcome or endpoints using biomarkers, also known as variables or predictors, in as safe, efficient, and accurate a manner as possible. This review addresses the concepts and possible strategies for use of predictor and surrogate biomarkers in the design of clinical trials in renal transplantation. The statistical concepts apply equally well to other organ grafts.
Related Concept Videos
Kidney Transplant I: Introduction
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Kidney Transplant III: Nursing Management
Kidney Transplant II: Surgical Procedure
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
